ATE148629T1 - Mehrkomponentenwirkstoff oder kit zur herstellung von sulfokonjugierten formen von pyridino-, pyrimidino- oder triazino-n-oxydeverbindungen und verfahren zu ihrer verwendung - Google Patents

Mehrkomponentenwirkstoff oder kit zur herstellung von sulfokonjugierten formen von pyridino-, pyrimidino- oder triazino-n-oxydeverbindungen und verfahren zu ihrer verwendung

Info

Publication number
ATE148629T1
ATE148629T1 AT91403479T AT91403479T ATE148629T1 AT E148629 T1 ATE148629 T1 AT E148629T1 AT 91403479 T AT91403479 T AT 91403479T AT 91403479 T AT91403479 T AT 91403479T AT E148629 T1 ATE148629 T1 AT E148629T1
Authority
AT
Austria
Prior art keywords
triazino
pyrimidino
pyridino
kit
compounds
Prior art date
Application number
AT91403479T
Other languages
English (en)
Inventor
Quintino Gaetani
Andre Rougier
Albert Duranton
Michel Hocquaux
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE148629T1 publication Critical patent/ATE148629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT91403479T 1990-12-28 1991-12-20 Mehrkomponentenwirkstoff oder kit zur herstellung von sulfokonjugierten formen von pyridino-, pyrimidino- oder triazino-n-oxydeverbindungen und verfahren zu ihrer verwendung ATE148629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016504A FR2671082B1 (fr) 1990-12-28 1990-12-28 Agent a plusieurs composants ou kit de preparation de la forme sulfo-conjuguee de composes pyrimidino- ou triazino-n-oxyde et procede de mise en óoeuvre.

Publications (1)

Publication Number Publication Date
ATE148629T1 true ATE148629T1 (de) 1997-02-15

Family

ID=9403848

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91403479T ATE148629T1 (de) 1990-12-28 1991-12-20 Mehrkomponentenwirkstoff oder kit zur herstellung von sulfokonjugierten formen von pyridino-, pyrimidino- oder triazino-n-oxydeverbindungen und verfahren zu ihrer verwendung

Country Status (8)

Country Link
US (1) US5360804A (de)
EP (1) EP0494005B1 (de)
JP (1) JP3115072B2 (de)
AT (1) ATE148629T1 (de)
CA (1) CA2058471A1 (de)
DE (1) DE69124591T2 (de)
ES (1) ES2097198T3 (de)
FR (1) FR2671082B1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
AU761737B2 (en) * 1998-06-03 2003-06-12 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
EP1085853A1 (de) 1998-06-03 2001-03-28 GPI NIL Holdings, Inc. Haarwuchszusammensetzungen basiernd auf heterozyklischem ester und amid und anwendungen
WO1999062880A1 (en) 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
GB2423087A (en) * 2005-02-07 2006-08-16 Reckitt Benckiser A method of forming a surface treatment liquid,of treating a surface, of cleaning a surface and a packaged composition therefor
EP1850663A4 (de) * 2005-02-22 2008-03-19 Cedars Sinai Medical Center Verwendung von minoxidilsulfat als wirkstoff gegen krebs
JP7194553B2 (ja) * 2017-10-12 2022-12-22 ロート製薬株式会社 外用組成物
US11628132B2 (en) 2018-10-05 2023-04-18 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
US12533309B2 (en) 2018-10-05 2026-01-27 Caring Brands, Inc. Minoxidil adjuvant therapies
US11766392B2 (en) * 2018-10-05 2023-09-26 Jupiter Wellness, Inc. Minoxidil adjuvant therapies

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053113A (de) * 1963-04-19
US3270018A (en) * 1964-02-13 1966-08-30 Upjohn Co 1, 3, 5-triazine ethers
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3348943A (en) * 1965-08-27 1967-10-24 Bernard D Pollock Refractory metal dispersion
US3910928A (en) * 1974-04-26 1975-10-07 Upjohn Co 3-(Cyanimino)-propionitriles
US4032559A (en) * 1975-07-28 1977-06-28 The Upjohn Company N,2-dicyanoacetimidates
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
WO1986004231A1 (en) * 1985-01-25 1986-07-31 The Upjohn Company Pyrimidine sulfates for hair growth
FR2590897B1 (fr) 1985-12-06 1988-02-19 Kemyos Bio Medical Research Sr Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant
JPS62158204A (ja) * 1985-12-28 1987-07-14 Banyu Pharmaceut Co Ltd 育毛剤
LU87308A1 (fr) * 1988-08-01 1990-03-13 Oreal Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
FR2657609B1 (fr) * 1990-01-31 1992-04-30 Oreal Nouveaux derives de pyrimidine oxyde-3 halogenes, leur utilisation pour le traitement et la prevention de la chute des cheveux et pour stimuler leur repousse.
FR2651122B1 (fr) * 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
FR2662607B1 (fr) * 1990-05-30 1992-08-28 Oreal Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
FR2663327B1 (fr) * 1990-06-19 1992-09-25 Oreal Nouveaux derives de diamino-2,4 triazine-1,3,5 et leur utilisation pour le traitement et la prevention de la chute des cheveux.

Also Published As

Publication number Publication date
EP0494005B1 (de) 1997-02-05
US5360804A (en) 1994-11-01
JPH04308576A (ja) 1992-10-30
ES2097198T3 (es) 1997-04-01
DE69124591D1 (de) 1997-03-20
FR2671082A1 (fr) 1992-07-03
CA2058471A1 (fr) 1992-06-29
FR2671082B1 (fr) 1993-04-16
DE69124591T2 (de) 1997-05-28
EP0494005A1 (de) 1992-07-08
JP3115072B2 (ja) 2000-12-04

Similar Documents

Publication Publication Date Title
DE69124591D1 (de) Mehrkomponentenwirkstoff oder Kit zur Herstellung von sulfokonjugierten Formen von Pyridino-, Pyrimidino- oder Triazino-N-Oxydeverbindungen und Verfahren zu ihrer Verwendung
DE3684085D1 (de) Reinigungsmittelzusammensetzung und verfahren zu deren herstellung.
DE3773739D1 (de) Stabile spuelhilfsmittelzusammensetzung und verfahren zu deren herstellung.
DE68923204D1 (de) Faserverstärkte Polyamid-Zusammensetzung und Verfahren zu deren Herstellung.
DE3773608D1 (de) Mit fasern verstaerkte kautschukmischung, verfahren zu deren herstellung und deren verwendung.
DE68912657D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
DE3671897D1 (de) Deoxyadenosinphosphat-verbindungen und verfahren zur herstellung und anwendung.
DE69011473D1 (de) Gummidichtungen und Verfahren zu ihrer Herstellung.
DE3778262D1 (de) Detergenszusammensetzung und verfahren zu ihrer herstellung.
DE69431853D1 (de) Verfahren zur Herstellung von 1,1,3,3,3-Pentafluorpropen
DE69410722D1 (de) Verfahren zur Herstellung 1,4-bissubstituierter-5(4H)-Tetrazolinone
DE68924233D1 (de) Entwicklerzusammensetzung und Verfahren zu deren Herstellung.
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
DE3789569D1 (de) Zementzusammensetzung und Verfahren zu ihrer Herstellung.
DE3684632D1 (de) Tonerzusammensetzung und verfahren zur herstellung.
DE3880287D1 (de) Chlortrifluoraethylen-telomere und verfahren zu ihrer herstellung.
DE69401368D1 (de) Verfahren zur Herstellung von 1,4-Dicyano-2-buten
DE3886936D1 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE69016882D1 (de) Entwickler und Verfahren zu seiner Herstellung.
DE3873427D1 (de) Schmiermittelzusammensetzungen und verfahren zu deren herstellung.
ATA133390A (de) Neue penamderivate und deren salze, verfahren zur herstellung derselben und dieselben enthaltende antibakterielle mittel
AT377586B (de) Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen
DE58903604D1 (de) Ammonium- und immoniumverbindungen und verfahren zu ihrer herstellung.
DE3851541D1 (de) Propylen-äthylen-kopolymer-zusammensetzung und verfahren zur herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties